These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

193 related items for PubMed ID: 15156002

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Clinical outcomes following percutaneous coronary intervention with drug-eluting vs. bare-metal stents in dialysis patients.
    Halkin A, Selzer F, Marroquin O, Laskey W, Detre K, Cohen H.
    J Invasive Cardiol; 2006 Dec; 18(12):577-83. PubMed ID: 17197706
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Procedural success versus clinical risk status in determining discharge of patients after primary angioplasty for acute myocardial infarction.
    Heggunje PS, Harjai KJ, Stone GW, Mehta RH, Marsalese DL, Boura JA, O'Neill WW, Grines CL.
    J Am Coll Cardiol; 2004 Oct 06; 44(7):1400-7. PubMed ID: 15464319
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. [Percutaneous transluminal coronary angioplasty in patients with high risk bypass surgery].
    Norwa-Otto B, Dabrowski M, Jodkowski J, Witkowski A, Debski A, Chmielak Z, Woroszylska M, Demkow M, Juraszyński Z, Hendzel P.
    Kardiol Pol; 1992 Oct 06; 37(10):203-7. PubMed ID: 1464996
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Utility of detailed preoperative cardiac testing and incidence of post-thoracotomy myocardial infarction.
    Jaroszewski DE, Huh J, Chu D, Malaisrie SC, Riffel AD, Gordon HS, Wang XL, Bakaeen F.
    J Thorac Cardiovasc Surg; 2008 Mar 06; 135(3):648-55. PubMed ID: 18329488
    [Abstract] [Full Text] [Related]

  • 31. Sirolimus-eluting stent treatment at high-volume centers confers lower mortality at 6-month follow-up: results from the prospective multicenter German Cypher Registry.
    Khattab AA, Hamm CW, Senges J, Toelg R, Geist V, Bonzel T, Kelm M, Levenson B, Nienaber CA, Pfannebecker T, Sabin G, Schneider S, Tebbe U, Neumann FJ, Richardt G, German Cypher Registry.
    Circulation; 2009 Aug 18; 120(7):600-6. PubMed ID: 19652087
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Long-term outcomes of coronary-artery bypass graft surgery versus percutaneous coronary intervention for multivessel coronary artery disease in the bare-metal stent era.
    Kimura T, Morimoto T, Furukawa Y, Nakagawa Y, Shizuta S, Ehara N, Taniguchi R, Doi T, Nishiyama K, Ozasa N, Saito N, Hoshino K, Mitsuoka H, Abe M, Toma M, Tamura T, Haruna Y, Imai Y, Teramukai S, Fukushima M, Kita T.
    Circulation; 2008 Sep 30; 118(14 Suppl):S199-209. PubMed ID: 18824755
    [Abstract] [Full Text] [Related]

  • 34. Effect of gender on prognosis following percutaneous coronary intervention for stable angina pectoris and acute coronary syndromes.
    Glaser R, Selzer F, Jacobs AK, Laskey WK, Kelsey SF, Holper EM, Cohen HA, Abbott JD, Wilensky RL.
    Am J Cardiol; 2006 Dec 01; 98(11):1446-50. PubMed ID: 17126647
    [Abstract] [Full Text] [Related]

  • 35. Coronary artery bypass surgery versus percutaneous coronary intervention with drug-eluting stent implantation in patients with multivessel coronary disease.
    Yang ZK, Shen WF, Zhang RY, Kong Y, Zhang JS, Hu J, Zhang Q, Ding FH.
    J Interv Cardiol; 2007 Feb 01; 20(1):10-6. PubMed ID: 17300391
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Randomized comparison of everolimus-eluting and paclitaxel-eluting stents: two-year clinical follow-up from the Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System in the Treatment of Patients with de novo Native Coronary Artery Lesions (SPIRIT) III trial.
    Stone GW, Midei M, Newman W, Sanz M, Hermiller JB, Williams J, Farhat N, Caputo R, Xenopoulos N, Applegate R, Gordon P, White RM, Sudhir K, Cutlip DE, Petersen JL, SPIRIT III Investigators.
    Circulation; 2009 Feb 10; 119(5):680-6. PubMed ID: 19171853
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.